In EBV-associated PTLD, cell growth is driven by the EBV growth program (also referred to as type III latency) characterized by the expression of (1) nine protein-coding genes (nuclear antigens EBNA-1, -2, -3A, -3B, -3C, LP, and latency membrane proteins LMP-1, -2A, -2B), (2) EBER non-coding RNAs, and (3) miRNAs (Table 1). Here, PDLIM7 is linked to post-transplant lymphoproliferative disease.